NDC 0006-5369 – Segluromet
Ertugliflozin Pidolate 2.5 mg/1; Metformin Hydrochloride 500 mg/1 · Tablet, Film Coated · Oral
Product NDC0006-5369
Product details
- Brand name
- Segluromet
- Generic name
- Ertugliflozin and metformin hydrochloride
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA209806
- Marketed since
- December 19, 2017
- Listing expires
- December 31, 2027
- Pharmacologic class
- Biguanide
Active ingredients
- Ertugliflozin Pidolate 2.5 mg/1
- Metformin Hydrochloride 500 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 0006-5369-03 | 60 TABLET, FILM COATED in 1 BOTTLE (0006-5369-03) | Dec 19, 2017 |
| 0006-5369-06 | 180 TABLET, FILM COATED in 1 BOTTLE (0006-5369-06) | Dec 19, 2017 |
| 0006-5369-07 | 500 TABLET, FILM COATED in 1 BOTTLE (0006-5369-07) | Dec 19, 2017 |
Other Segluromet products
- 0006-5370 Ertugliflozin Pidolate 7.5 mg/1; Metformin Hydrochloride 500 mg/1 · Tablet, Film Coated · Merck Sharp & Dohme LLC
- 0006-5373 Ertugliflozin Pidolate 2.5 mg/1; Metformin Hydrochloride 1000 mg/1 · Tablet, Film Coated · Merck Sharp & Dohme LLC
- 0006-5374 Ertugliflozin Pidolate 7.5 mg/1; Metformin Hydrochloride 1000 mg/1 · Tablet, Film Coated · Merck Sharp & Dohme LLC